The Global Asset Purchase Deals in Pharma, Biotech and Diagnostics 2014-2021 report provides a detailed understanding and analysis of how and why companies enter business, product, technology and royalty asset purchase deals
| Published | Pages | Publisher | Report code |
|---|---|---|---|
| Oct 2021 | 700 | DelveInsight | ASDR-591702 |
The Global Asset Purchase Deals in Pharma, Biotech and Diagnostics 2014-2021 report provides a detailed understanding and analysis of how and why companies enter business, product, technology and royalty asset purchase deals
Published: October, 2019 | Report code: ASDR-483780
US $
Euro €
GBP £